gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE American · MYOHealthcareOrthopedic & Surgical Supplies

Myomo Inc. (MYO)

$1.29+0.78%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$1.29▲ 48.65% in range
Nov 3, 2025Low $0.64 · High $1.86Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Myomo closed at $1.29 on Nov 4, up 0.78%, 30.6% below its 52-week closing high. Volume of 125.2K shares was 0.54× its 20-day average (below normal).

Split-adjusted performance: -19.9% over one month, +51.2% over six months, +48.7% over one year.

In the quarter ended Jun 30, 2026, revenue was $11.70M, up 21.3% from a year earlier, with a net margin of -34.4%.

Short interest was 1.1M shares at the Oct 15 settlement (2.9% of float, 3.9 days to cover).

Market cap$51.1M39.6M shares
Revenue · quarter$11.7M+21.3% YoY
Diluted EPS$-0.09—
P/E · TTM—P/S 1.2×
Net margin-34.4%Gross 72.1%
Dividend yieldNone
52-week range0.64 – 1.86−30.6% from high
Volume125.2K0.54× 20-day avg
Volatility · 60d92.3%Annualised
Short % of float2.9%3.9 days to cover
Net cash$1.5MCash $13.5M
Next earnings—Not scheduled
Split-adjusted performance
1W +2.4%1M −19.9%3M −1.5%6M +51.2%YTD +41.8%1Y +48.7%3Y +18.3%5Y −87.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Orthopedic & Surgical Supplies

Percentile among 22 companies (100 = best)

6-month momentum90
Revenue growth68
Net margin32
Value (low P/E)—
Size14

Industry medians: 6-month return +1.5%, revenue growth +12.8%, net margin −2.8%, P/E 29.2×.

Short interest

Details →
Shares short1.1M−0.2% vs prior
Days to cover3.9Settled Oct 15
% of float2.9%
Short vol. 10d52.2%of daily volume

Closest peers by size in Orthopedic & Surgical Supplies

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
MYOMyomo$1.29+0.78%+51.2%+21.3%−34.4%—$51.1M
COCHEnvoy Medical$6.88+3.85%+1.8%−34.6%−14258.8%—$53.2MCompare
APTAlpha Pro Tech$5.71+2.70%+21.5%+12.0%9.8%13.9$58.3MCompare
SPAISafe Pro Group$3.25+2.52%−27.3%+1336.2%−237.9%—$66.2MCompare
CNXUConexeu Sciences$2.17−8.82%————$66.9MCompare
NTRBNutriband$6.09−3.10%+53.5%−29.7%−201.3%—$74.1MCompare
LAKELakeland Industries$8.96+0.22%−7.0%−4.5%−9.8%—$89.0MCompare
MLSSMilestone Scientific$0.3170+4.31%−21.4%+22.3%−37.3%—$28.7MCompare
LFWDLifeward$6.03+3.34%−13.9%+15.7%−173.9%—$17.1MCompare

News about Myomo

All news →

No recent articles focused on Myomo.

Quick answers

What does Myomo do?
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device.
What is MYO's market cap?
$51.09M, based on the Nov 4 close of $1.29.
Does Myomo pay a dividend?
No regular cash dividend has been paid in the last year.
How much of MYO is sold short?
1.1M shares, 2.9% of float, as of Oct 15, 2026.
What sector is MYO in?
Healthcare, in the Orthopedic & Surgical Supplies industry.

About Myomo

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

HQ: Boston, MA195 employeesListed Jun 12, 2017myomo.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology